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1. 
SCAFFOLD FOR BONE AND TISSUE REPAIR 
IN MAMMALS 
FIELD OF THE INVENTION 
This invention relates to a biocompatible scaffold for 
implantation into mammals to facilitate bone and tissue 
repair, regeneration, and proliferation. 
BACKGROUND OF THE INVENTION 
The use of tissue scaffold to facilitate the repair and 
regrowth of bone and other tissue is known in the art, for 
example, from U.S. Pat. No. 7.338,517 which discloses an 
implantable scaffold with biopolymer fibrils aligned in heli 
cal patterns of opposite directions. 
U.S. Pat. No. 7,416,564 describes a bone scaffold made 
from porous ceramic Substrate of a material Such as Zirconia 
which is then coated with a fluorapatite layer and a hydroxya 
patite layer. The porous Substrate was prepared by dipping a 
foam template into a slurry. The porosity is aligned irregularly 
and randomly and does not run continuously along a longi 
tudinal axis from one end of the object to the other end. The 
fabrication requires repeated dipping and drying. 
SUMMARY OF THE INVENTION 
Briefly, therefore, the invention is directed to a tissue scaf 
fold comprising a rigid scaffold body having a scaffold cen 
tral axis, a scaffold transverse dimension, and a scaffold 
lengthwise dimension which is greater than the scaffold 
transverse dimension, the scaffold body having a compres 
sive strength between about 20 and about 250 MPa and com 
prising biocompatible inorganic glass fibers each having a 
fiber transverse dimension and a fiber lengthwise dimension 
which is at least about 10 times the fiber transverse dimen 
sion; and an interconnected porosity constituting between 
about 10 vol.% and about 35 vol. % of the scaffold body; 
wherein each of the fibers has a diameter between about 20 
and about 5000 microns; wherein the fibers are bonded 
together; and wherein at least about 75 vol% of the fibers 
extend generally in the direction of the scaffold central axis, 
are generally free of helical orientation about the scaffold 
central axis, and are arranged to define open channels within 
the scaffold which allow fluid flow into and lengthwise within 
the scaffold. 
In another aspect the invention is directed to a tissue scaf 
fold comprising a rigid scaffold body having a central axis, a 
scaffold transverse dimension, and a scaffold lengthwise 
dimension which is greater than the scaffold transverse 
dimension, the scaffold body having a compressive strength 
between about 20 and about 250 MPa and comprising: bio 
compatible inorganic glass fibers each having a fiber trans 
verse dimension and a fiber lengthwise dimension which is at 
least about 10 times the fiber transverse dimension; and an 
interconnected porosity constituting between about 10 Vol.% 
and about 35 Vol.% of the scaffold body; wherein the fibers 
are bonded together; wherein each of the fibers has a diameter 
between about 20 and about 5000 microns; and wherein at 
least about 75 vol% of the fibers extend generally parallel to 
the scaffold central axis, and are arranged to define open 
channels within the scaffold which allow fluid flow into and 
lengthwise within the scaffold. 
The invention is also directed to a tissue scaffold compris 
ing a scaffold body having a central axis, a scaffold transverse 
dimension, and a scaffold lengthwise dimension which is 













body comprising: biocompatible inorganic glass fibers each 
having a fiber transverse dimension and a fiber lengthwise 
dimension which is at least about 10 times the fibertransverse 
dimension; and an interconnected porosity constituting 
between about 10 vol.% and about 35 vol.% of the Scaffold 
body; wherein each of the fibers has a diameter between about 
20 and about 5000 microns; wherein the fibers are bonded 
together; wherein at least about 75 vol% of the fibers extend 
generally in the direction of the scaffold central axis, and are 
arranged to define open channels lengthwise through a core 
within the scaffold, which channels allow fluid flow into and 
lengthwise within the scaffold. 
In another aspect the invention is directed to a method for 
making a tissue scaffold comprising: heating inorganic bio 
compatible glass fibers in a mold to a temperature where the 
fibers partially fuse to each other to form a rigid scaffold body 
having a scaffold central axis, a scaffold transverse dimen 
Sion, and a scaffold lengthwise dimension which is greater 
than the scaffold transverse dimension, the scaffold body 
having an interconnected porosity between about 10 Vol.% 
and about 35 Vol.%, a compressive strength between about 20 
and about 250 MPa; wherein the biocompatible glass fibers 
each has a fiber transverse dimension and a fiber lengthwise 
dimension which is at least about 10 times the fibertransverse 
dimension; wherein the fibers have a diameter between about 
20 and about 5000 microns; and wherein at least about 75 vol 
% of the fibers extend generally in the direction of the scaffold 
central axis, are generally free of helical orientation about the 
scaffold central axis, and are arranged to define open channels 
within the scaffold which allow fluid flow into and lengthwise 
within the scaffold. 
Other objects and features of the invention are in part 
apparent and in part pointed out hereinafter. 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. 1A is an optical micrograph of a transverse cross 
section of a scaffold of the invention formed by heating fibers 
at 700° C. for a relatively shorter time than with the scaffold 
in FIGS. 1B and 1C. 
FIGS. 1B and 1C are SEM photographs of a transverse 
cross section of the scaffold of the invention formed by heat 
ing fibers at 700° C. for a relatively longer time than with the 
Scaffold in FIG. 1A. 
FIG. 2 is a photograph of a lengthwise cross section of the 
scaffold of the invention showing lengthwise and parallel 
alignment of fibers. 
FIGS. 3A, 3B, and 3C are a series of photographs showing 
the manufacturing progression of a unidirectional scaffold 
from loose fibers to a self-bonded scaffold of the invention. 
FIGS. 4A and 4B are photographs of a segment of scaffold 
of the invention after immersion in an osteoblast cell culture 
and MTT labeling. 
FIGS. 5 and 6 are graphical plots of open porosity and 
compressive strength data of scaffolds of the invention. 
FIG. 7 is a photograph of a scaffold of the invention next to 
a chicken bone. 
FIGS. 8 and 9 are still frames extracted from videos taken 
of experiments described in the working examples. 
FIGS. 10, 12, and 13 are schematic depictions of alterna 
tive reinforced scaffold embodiments of the invention. 
FIG. 11 is a photograph of a scaffold according to the 
Schematic of FIG. 10. 
DESCRIPTION OF PREFERRED 
EMBODIMENTS 
The tissue scaffold of the present invention is prepared 
from fibers which are aligned so that a majority of the fibers 
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are substantially aligned in a parallel direction. The scaffold is 
prepared by placing and orienting fibers in a unidirectional 
manner in a mold. The fibers in the mold are heated to a 
temperature where the fibers soften and bond together. In one 
preferred embodiment, the fibers are self bonded in the sense 
that no adhesive, braze, or other external bonding agent is 
used for bonding. An alternative embodiment employs a bio 
compatible agent or adhesive to facilitate bonding, such that 
the fibers are not self bonded, at least in part. Upon cooling, 
the assemblage of bonded fibers is sufficiently rigid and 
strong that the assemblage can be removed from the mold and 
handled. The scaffold is sufficiently rigid that it can be 
implanted into a mammal where it facilitates the repair and 
regeneration of hard tissue Such as bone (including cortical 
and cancellous) or soft tissue such as muscle, cartilage, skin, 
organ, or other hard or soft tissue. 
The orientation of the fibers in a lengthwise direction in the 
self bonded scaffold provides lengthwise channels (or con 
nected pores) among the fibers, which channels provide for 
uptake into the scaffold of stem cells, growth factors, medi 
cines, red blood cells and other bodily fluids and components 
carried in bodily fluids. The fibers are arranged to define 
channels within the scaffold which facilitate fluid flow into 
and lengthwise within the scaffold from one end to the other 
end. The orientation also provides for channels in a transverse 
direction generally perpendicular to the lengthwise direction 
of the oriented fibers, to facilitate uptake of fluids from the 
outer surface of the interior or core of the scaffold. These 
longitudinal and transverse channels exert significant capil 
lary forces on a liquid which cause the liquid to be drawn into 
the scaffold. This capillary action facilitates the distribution 
of these fluids and components relatively uniformly through 
the scaffold and enables fluids to flow from one end of the 
scaffold to the other or to enter the scaffold from its surface 
and transmit the liquid to its ends. 
The invention in one embodiment employs fibers having a 
diameter, prior to molding and softening, between about 20 
and about 5000 microns, such as between about 50 and about 
5000 microns. In one embodiment the scaffold is prepared 
from fibers having diameters between about 100 and about 
450 microns, such as between about 100 and about 300 
microns. In an alternative embodiment, the scaffold is pre 
pared from fibers having diameters up to about 3000 or 5000 
microns (3 to 5 mm), which can be deemed more akin to rods 
than fibers in some contexts, but for purposes of the discus 
sion of this invention fall within the definition of “fibers.” 
FIG. 1A is an optical micrograph of a cross section of a 
scaffold of the invention showing the self-bonded fibers and 
pores after heating the fibers at 700° C. for 15 minutes. FIGS. 
1B and 1C, which are SEM photographs of a transverse cross 
section of a different scaffold of the invention having under 
gone a greater degree of softening and bonding than the 
scaffold of FIG. 1A, show that after molding and joining to a 
greater degree (heating at 700° C. for 45 minutes), the trans 
verse cross section of each fiberis no longerprecisely circular 
as it is in a freshly formed fiber. Rather, the softening of the 
fibers and fusing of adjacent fibers to each other imparts an 
irregular and irregularly rounded shape to the fibers in trans 
verse cross section. The transverse cross sections here reflect 
joined fiber cross sections ranging in width loosely, diam 
eter—from about 50 to about 300 microns. 
The fibers in the scaffold are bonded together and therefore 
are not loose fibers; but they retain their identities as separate 
fibers as shown in FIG. 2, which is a photograph of a longi 
tudinal cross section of a scaffold (heated at 700° C.) of the 
invention. In one aspect of the invention, at least about 75 or 













co-aligned. In this regard the fibers are co-aligned longitudi 
nally, where “co-aligned longitudinally and the like phrases 
(e.g., “in lengthwise co-alignment') as applied to a group of 
adjacent, bundled, or joined fibers in this application means 
that the alignment of each fiber in the group at any one place 
along at least about 75% of its length does not deviate more 
than about 25 degrees from parallel to the central axis of the 
scaffold. In one preferred embodiment, each fiber in the group 
at any one place along at least about 75% of its length does not 
deviate more than about 15 degrees from parallel to the cen 
tral axis of the scaffold. In another preferred embodiment, 
each fiber in the group at any one place along at least about 
75% of its length does not deviate more than about 10 degrees 
from the central axis of the scaffold. So it is evident that this 
co-alignment aspect does not require 100% precise co-align 
ment of all fibers. The longitudinal co-alignment aspect also 
allows for Some minor deviation of specific segments of indi 
vidual fibers to an orientation outside these 25, 15, and 10 
degree requirements. This is reflected in the requirement that 
the longitudinal co-alignment is of each fiber along at least 
75% of its length, rather than necessarily along its entire 
length. So up to about 25% of the length of an individual fiber 
may be misaligned because, for example, it was bent during 
the scaffold-making process or otherwise. It can be seen 
therefore in FIG. 2 that each fiber in the scaffold is not 
absolutely straight, nor is it lying along an absolutely straight 
line strictly parallel to all other fibers in the scaffold. And each 
fiber is oriented generally in the same direction, but each is 
not oriented in exactly the same direction. Moreover, the 
scaffold itself in certain embodiments is curved, bent, or 
otherwise not straight, in which cases the central axis of the 
scaffold to which the alignment of the fibers is within 25 
degrees of parallel is also curved, bent, or otherwise not 
straight. It will also be evident that in certain embodiments a 
straight or curved scaffold will be machined into a more 
complex shape as in FIGS. 7A and 7B, in which instance the 
scaffold central axis refers to the central axis as molded and 
prior to machining. 
In order to allow capillary action and channel-forming, the 
scaffold theoretically contains at least three fibers, although 
from FIG. 2 it can be seen that the scaffold typically com 
prises dozens and even hundreds of fibers. It can also be seen 
that the fibers lie generally lengthwise of the scaffold central 
axis A (i.e., lie generally in the direction of the central axis) 
and are generally free of helical orientation about the scaffold 
central axis. This arrangement applies to at least about 75 Vol 
% of the fibers and preferably to substantially all of the fibers. 
The fibers shown here extend generally parallel to the scaffold 
central axis A, which is also illustrated as axis B in FIG. 3C, 
and axis C in FIG. 7B. This embodiment also manifests an 
optional feature that at least about 75 vol% of the fibers 
occupies the entire length of the scaffold; but in other embodi 
ments this is not the case. 
The requirement of the invention that the fibers are co 
aligned longitudinally contemplates that the fibers are posi 
tioned so that they have a similar alignment, which similar 
alignment may be straight, bent, or curved. In a separate and 
distinct aspect of certain preferred embodiments, this com 
mon alignment is limited to a generally straight alignment 
along at least about 75%, 85%, or 95% of the length of the 
fibers. In other words, at least about 75%, 85%, or 95% of 
each fiber is generally straight, i.e., at least about 75%, 85%, 
or 95% of the length of each fiber has an alignment which is 
within 10 degrees of a mean straight central axis for the fiber. 
So up to 5%, 15%, or 25% of the length of each fiber may be 
curved, bent, or otherwise deviate more than 10 degrees from 
straight in relation to the overall fiber length, but the rest of 
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each fiber is generally straight in that it so deviates less than 
10 degrees. In one preferred embodiment, substantially the 
entire length of each fiber is generally straight in that it devi 
ates less than 10 degrees from the fiber's average central axis. 
The “mean Straight central axis' is the imaginary central axis 
for the fiber which is absolutely straight and is an average of 
all axes along the fiber length. 
The fibers in the scaffold are selected to have characteris 
tics Suitable for the specific application. In one embodiment, 
the fibers have a length between about 6 mm and about 15 cm, 
such as between about 12 mm and about 10 cm or between 
about 25 mm and about 75 mm. Each fiber has a length which 
is at least about 10 times its diameter. "Diameter' as used 
herein refers to the fibers largest dimension transverse to its 
length, and it does not imply that the fibers are perfectly 
circular in cross section. Each fiber therefore has a fiber 
lengthwise dimension which is at least about 10 times the 
fiber transverse dimension, e.g., diameter. In one embodi 
ment, the fiber length is selected so that all, substantially all, 
or at least about 85 vol% of the individual fibers extend the 
entire length of the scaffold. The fibers may be selected to 
have a pre-molding, pre-joining length which corresponds to 
the length of the scaffold. Or in most embodiments, the length 
of the fibers is longer than the desired ultimate scaffold 
length, and the scaffold is cut to the desired length after 
molding and joining. In an alternative embodiment, the length 
of a substantial portion (e.g., at least 40 vol%) or all of the 
fibers is significantly less than the entire length of the scaf 
fold. 
FIGS. 1A, 1B, 1C, 4A and 4B also demonstrate the open 
and interconnected porosity of the scaffold of the invention. 
The scaffold is manufactured to have a sufficiently high open 
and interconnected porosity from end to end of the scaffold to 
facilitate capillary flow of fluids such as bodily fluids and 
medicines and components they carry through the length of 
the scaffold, as well as generally transverse from outside 
walls of the scaffold into the scaffold interior in directions 
generally transverse to the longitudinal dimension of the 
fibers. And the scaffold is manufactured so that the ultimate 
porosity is low enough that the scaffold has required strength 
for handling, implantation, and service after implantation. If 
the porosity is too high, the scaffold risks breakage in service, 
depending on where it is implanted and the loads it encoun 
ters. In a preferred embodiment, the porosity as measured in 
volume is between about 10% and about 35%, for example 
between about 10% and about 30%, or between about 10% 
and about 25%. The porosity is controllable mainly by con 
trolling the degree of softening of the fibers, in that highly 
softened fibers fuse together more completely to a structure 
with lower porosity. The degree of softening and fusing is 
controlled by controlling the joining temperature and time. 
Porosity is also affected by the fiber diameter and by the range 
in fiber diameter within a given scaffold. Porosity tends to 
increase with an increasing range in fiber diameter. 
The scaffold of the invention in certain preferred embodi 
ments for use in bone repair has a compressive strength 
between about 20 and about 250 MPa, for example between 
about 20 and about 180 MPa or between about 80 and about 
140 MPa. 
The fibers used in many embodiments of the invention are 













amorphous or non-crystalline solid, for example made by 
fusing a mixture of oxides such as SiO, BO, POs (known 
as glass forming oxides) with basic oxides such as the alkali 
and alkaline earth oxides. In an alternative embodiment, the 
fibers include glass ceramics fibers that contain both glassy 
and crystalline regions which in many respects function in the 
same manner as a fiber that is completely (100%) non-crys 
talline. It is acceptable in some applications if the glass fiber 
crystallizes during the bonding step. The fibers may alterna 
tively be pre-reacted bioactive glasses Such as glass fibers 
pre-reacted to have a thin Surface layer of hydroxyapatite. 
These foregoing different types offibers are within a common 
group which are referred to herein as "glass fibers.” In a 
further alternative, the unidirectional scaffold comprises 
crystalline fibers (such as titanium wires) that would also 
provide a high amount of capillary action. Alternatively, the 
scaffold comprises a mix of different types of fibers selected 
from among these. 
The fibers are preferably made from a material which is 
inorganic and which is biocompatible in that the fibers do not 
have adverse effects when implanted into mammals. Biocom 
patible materials include both bioactive and bioinert materi 
als. In certain preferred embodiments, the fibers are also of a 
bioactive glass in that they are of a glass material which reacts 
with phosphorus such as phosphorus in bodily fluids to form 
hydroxyapatite. Bioactive glasses are known in the art, for 
example, from U.S. Pat. No. 6,054,400; the entire disclosure 
of which is incorporated herein by reference. Bioactive 
glasses are available, for example, from Mo-Sci Corporation 
of Rolla, Mo. In other embodiments, some or all of the fibers 
may be bioinert rather than bioactive, such as 100% bioinert 
fibers or a roughly 50/50 mix of bioinert and bioactive fibers. 
In general, bioactive glass is one which contains calcium 
and, when placed in contact with natural body fluids or simu 
lated body fluids, forms a bicompatible calcium phosphate 
compound Such as hydroxyapatite. When Such a glass is 
immersed in or otherwise contacted with natural or simulated 
body fluids which contain phosphate ions such as in a mam 
mal, the glass dissolves, thereby releasing Ca" ions into the 
solution. In this solution, Ca" ions react with PO, and OH 
ions to form a calcium phosphate which has a relatively low 
solubility limit in the aqueous phosphate Solution. As the 
dissolution of the glass proceeds, the concentration of cal 
cium phosphate increases in the Solution until the solubility 
limit of calcium phosphate is exceeded and, as a consequence, 
hydroxyapatite (a form of calcium phosphate) is deposited as 
aporous layer on the outer Surface of the dissolving glass. The 
formation of this porous hydroxyapatite layer on the glass 
surface, however, does not prevent further dissolution of the 
glass. Rather, the glass continues to dissolve and, as it does, 
the thickness of the porous hydroxyapatite layer increases. 
Eventually, the glass is completely reacted or transformed, 
leaving only a porous hydroxyapatite Substance whose shape 
and size are the same as the initial glass fiber. Hydroxyapatite 
has crystallographic and chemical properties similar to those 
of mammalian bone. For example, human bone is a composite 
of fibrous protein, collagen, and hydroxyapatite. 
The material for use in the invention is also selected to be 
of a composition which is available in fibers or which can be 
pulled into fibers. Glass fibers can be made several ways. For 
example, glass fibers can be made by pulling by hand or with 
use of a rotating drum directly from a melt, or they can be 
pulled through abushing of aparticular size. The composition 
is preferably selected to be of a type which softens to facilitate 
self-joining at a temperature below its crystallization tem 
perature. Suitable bioactive glasses include, for example 
those listed in Table 1. 
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TABLE 1. 
Weight Percent Composition of Bioactive Glasses 
Li2O Na2O KO MgO CaO B.O. P-Os SiO2 
O 2O 10 5 10 O O 55 
O 18 9 O 14 1 4 54 
O 12 15 5 11 1 2 S4 
O 6 12 5 2O O 4 S3 
O 18 6 2 17 2 2 53 
O 15 12 2 11 3 4 S3 
O 2O 10 2 10 3 3 52 
O 2O 10 5 10 3 O 52 
O 25 5 2 10 3 3 52 
O 15 15 2 15 3 O 50 
O 6 12 5 2O 17.7 4 35.3 
O 6 12 5 2O 35.3 4 17.7 
O 6 12 5 2O 53 4 O 
O 21.5 O O 21.5 O 4 S3 
11.5 O O O 10 78.5 O O 
10.7 O O O 15 74.3 O O 
10 O O O 2O 70 O O 
Glasses which crystallize under fiber-pulling conditions 
and/or which crystallize at a temperature below that where 
they soften sufficiently for joining such as 45S5 have some 
limited applications here but are generally avoided in the 
preferred embodiments because they become too brittle and 
weak. Bioactive glasses such as 45S5 and other glasses that 
crystallize quickly not allowing sufficient self-bonding to 
occur may be bonded with sodium silicate or some other 
bonding agent to forman alternative scaffold embodiment of 
the invention; however the strength will likely be relatively 
low in comparison with self-bonded scaffolds. 
In forming the scaffold of the invention, a bundle of glass 
fibers such as the 6.25 cm long loose cut fibers shown in FIG. 
3A is placed as shown in 3B in a mold or similar vessel which, 
upon softening, joining, and cooling of the glass, will impart 
the desired final shape and strength to the scaffold. Each of the 
bundles inserted as shown in FIG.3B weighs about 2.4 grams 
and the mold is about 5.6 cm long. In one embodiment, this 
vessel is a graphite mold Such as a hollowed out cylinder as 
shown in 3B. The fibers are placed in the vessel tightly enough 
to fill the vessel cavity, but not so tightly as to risk breakage of 
the fibers or excessive densification. The vessel is then placed 
in a furnace and heated at a rate of about 20° C./min in the 
presence of a suitable atmosphere such as air, oxygen, or 
nitrogen. The temperature and the heating time are selected 
depending on the glass composition to achieve Softening and 
bonding of the fibers while avoiding too much bonding which 
would not achieve the desired porosity. The joining is prefer 
ably self-joining in that the softening of the glass accom 
plishes joining and no added joining agents are employed. 
That is, the scaffold body consists only of joined fiber ele 
ments and no other elements. As a general proposition, the 
vessel is heated to a temperature between about 500 and about 
800° C. and held at that temperature for between about 5 and 
about 60 minutes. For example, in one embodiment where the 
scaffold is formed from type 13-93 glass fibers to a finished 
dimension of about 62.5 mm long and about 6 mm in diam 
eter, the vessel is heated to a temperature between about 695 
and about 705 C. and held at that temperature for between 
about 5 and about 45 minutes. After bonding, the vessel and 
scaffold are cooled, preferably in air, at a rate which avoids 
cracking of the bonded fibers, such as between about 10 and 
about 30° C. per minute. 
The scaffold is then removed from the vessel and cut to the 
desired length to yield the product shown in FIG.3C. Cutting 














cutting the scaffold to length with a sharp, non-burring (e.g., 
diamond) saw, and then chemically or thermally removing 
the wax. Sharp corners and edges are avoided by making 
clean cuts while the scaffold is impregnated with wax, or a 
polish can be done with either grinding paper or a mechanical 
polishing device Such as a Dremel tool, also done while wax impregnated. 
The scaffold can be pre-reacted in a phosphate solution 
such as simulated body fluid (SBF) or an alkali phosphate 
Solution to form a reacted Surface layer of hydroxyapatite, 
prior to sterilization and implantation in a mammal. The 
hydroxyapatite surface layer thickness can be controlled by 
predetermined conversion kinetics of the glass in a phosphate 
containing Solution. Heat treatment of the glass can induce 
glass crystallization which may be beneficial in the formation 
of glass-ceramics or ceramics. Chemical (acid) etching may 
add surface roughness which could be beneficial to cell 
attachment. Heat treating the glass to cause phase separation 
to form multiple phases which could react at different rates 
and form a new microstructure within the individual self 
bonded fibers is desirable in certain applications. It is also 
within the scope of this invention to incorporate additives 
Such as growth factors, medicines, etc. into the scaffold body 
which perform a function Such as assist with tissue regrowth 
or supplement reinforcement of the body. In most preferred 
embodiments, such additives or reinforcements constitute 
less than about 10 Vol.% of the scaffold, such that the fibers 
and the porosity cumulatively constitute at least about 75 vol. 
% of the scaffold body, for example at least about 90 Vol.%. 
And in some embodiments there are no such additives or 
reinforcements, such that the scaffold body consists essen 
tially of the fibers and the porosity. 
After the wax has been removed, the scaffolds are steril 
ized. A preferred method among several possible is dry heat 
sterilization. The scaffolds are placed in a clean glass vial, 
covered with a clean aluminum foil cap, and heated to 
approximately 300° C. for three to four hours. Upon cooling, 
the sterile scaffolds are ready to be implanted. 
Growth factors, medicines such as antibiotics, seeded cells 
or other biological material, liquids or gels of any type, coat 
ings (particles, spheres, hollow spheres, thin film(s), fibers, 
and hollow fibers), an interpenetrating phase such as a bio 
degradable polymer or bone cement (PMMA) or other bio 
logical polymer, other organic or inorganic materials, or any 
combination may be added after sterilization to promote the 
growth of tissues into the scaffold. Additional sterilization 
may be required for Scaffolds that have had inorganic non 
sterile components added, and the method of sterilization 
may vary with the material(s) added. 
In one alternative embodiment of the invention, a titanium 
or other biocompatible Support such as a rod is incorporated 
into the scaffold to provide additional mechanical strength, as 
shown in FIGS. 10-13. 
The unidirectional scaffold of the invention is suitable in 
one aspect for forming a complete replacement bone or tissue 
segment where the mammals original bone or other tissue 
segment has been removed, crushed, decimated by disease or 
the like. In another aspect the scaffold is suitable as a bridge 
such as between about 2 mm and about 25 mm in length for 
bridging two separated bone segments. The scaffold is 
intended to serve as a temporary bridge for facilitating fluidic 
(e.g., marrow) communication (or transport) between the 
separated bone segments, thereby facilitating the healing of 
the broken bones. The scaffold also serves as an internal splint 
providing support for the bone fracture while the bone heals. 
Example 1 
Fibers of the bioactive glass type 13-93 (-2.4 grams) pro 
duced at Missouri University of Science & Technology hav 
US 8,353,966 B2 
ing diameters in the range of about 50 to about 400 microns 
and lengths of about 62 mm were placed inside a graphite 
mold formed by hollowing out a graphite cylinder. The mold 
was then placed in a furnace (Neytech Model 2-525) and 
heated in air to a temperature of about 700° C., where it was s 
held for times ranging from 5 to 45 minutes. The heat source 
was discontinued and the mold cooled to room temperature at 
an average cooling rate of about 30° C./min. Cylindrical 
scaffolds of unidirectional self-bonded fibers were removed 
from the mold, sectioned, and photographed to provide the 
images in FIGS. 1A, 1B, and 1C. The diameter of the scaf 
folds was 6 mm. FIG. 1A depicts a scaffold heated for a 
shorter period of time having a lower degree of self bonding, 
higher porosity, and lower strength. FIGS. 1B and 1C depict 
a scaffold heated for a longer period of time, having a greater 
degree of self bonding, lower porosity, and greater strength. 5 
In 1B and 1C the pore size is approaching too small, thereby 
inhibiting fluid flow in the scaffold in comparison to FIG. 1A. 
Open pores of at least about 100 microns in cross section are 




A 6 mm diameter by 20 mm thick section of a unidirec 
tional scaffold produced according to Example 1 was placed 
in a culture of osteoblast cells for four hours. MTT labeling 
was then performed on the section and photographs were 
taken (FIGS. 4A and 4B). The dark spots are due to the uptake 
of viable osteoblast-like cells into the scaffold. 
25 
E le 3 Xample 30 
Undirectional glass scaffolds were prepared in accordance 
with Example 1 with joining/heating times at 700° C. of 5, 15, 
30, and 45 minutes. The open porosity of each scaffold was 
then determined by the Archimedes liquid displacement 
method to be 35, 25, 15, and 18 vol%, respectively; see FIG. 
5. This degree of open porosity is within the range of human 
cortical bone and was achieved for scaffolds heated for 15, 30, 
and 45 minutes. 
35 
Example 4 40 
Unidirectional glass scaffolds were prepared inaccordance 
with Example 1 with joining/heating times at 700° C. of 5, 15, 
30, and 45 minutes. The average compressive strength of each 
scaffold was then determined by mechanical compression 
testing (Instron mechanical test instrument Model 4204 with 
a crosshead speed of 0.5 mm/min) to be 20, 80, 130, and 112 
MPa, respectively, see FIG. 6. This demonstrates that com 
pressive strengths within the range of human cortical bone 




A unidirectional scaffold was prepared in accordance with 
this invention by molding, bonding, cooling, and then 
machining to mimic the configuration of a chicken bone. FIG. 
7 shows the scaffold next to leg bone of a chicken. The 
scaffold of the invention, which is the lighter-colored of the 
two specimens closer to the ruler in FIG. 7, has a length of 
about 50 mm. This unidirectional scaffold is composed of 






A unidirectional cylindrical glass scaffold was prepared in 
accordance with Example 1 having a length of about 62 mm 
10 
and a diameter of about 6 mm. The fibers were type 13-93 
bioactive glass having a length of about 62 mm and diameters 
ranging from about 50 to about 400 microns. The fibers were 
oriented parallel to the longitudinal axis of the scaffold. The 
tip of the scaffold was dipped in a glycerol solution (34 wt % 
glycerol-66 wt % distilled water) as shown in FIG. 8. This 
solution has a viscosity of 2.5 centipoises at 25°C., which is 
in the average range for human blood. The purpose of this 
experiment was to demonstrate the strong capillary forces 
which this scaffold exerts upon a liquid resembling human 
blood. 
A roughly 40 second video of the experiment was filmed, 
and frames at 9, 11, 15, and 22 seconds are shown in FIGS. 
8A, 8B, 8C, and 8D, respectively. These frames show pro 
gressively upward darkening of the scaffold, which demon 
strates rapid capillary uptake of the Solution and its compo 
nents into the scaffold, and that the scaffold of the invention 
has strong capillary uptake of fluid in the direction of the 
longitudinal axis of the fiber scaffold. 
Example 7 
A cylindrical, unidirectional glass scaffold was prepared in 
accordance with Example 1 having a length of about 62 mm 
and a diameter of about 6 mm. The fibers were type 13-93 
bioactive glass fibers having a length of about 62 mm and a 
diameter of about 50 to 400 microns. The fibers were oriented 
parallel to the longitudinal axis of the scaffold. 
An eyedropper was used to drop the same water-glycerol 
solution as described in Example 6 onto the external surface 
of the scaffold as shown in FIG.9 for the purpose of demon 
strating the rapid capillary action of the scaffold in a direction 
perpendicular to the longitudinal axis of the scaffold. The 
Solution was dropped fairly quickly drop-by-drop onto the 
external surface of the scaffold until the scaffold became 
saturated with the solution. A video of this experiment was 
made over a 50 second period. Frames at 4 seconds (0 drops), 
12 seconds (3 drops), 18 seconds (6 drops), and 43 seconds 
(19 drops) are shown in FIGS. 9A, 9B, 9C, and 9D, respec 
tively. These frames show rapid capillary uptake of the solu 
tion and its components into the scaffold in both the length 
wise and transverse directions. This experiment demonstrates 
the scaffolds high affinity for the liquid and that the scaffold 
retained most of the drops before becoming saturated. At the 
conclusion of this experiment most of the liquid was retained 
in the scaffold and very little of the solution had dripped out 
of the scaffold into the bowl, as shown in 9D. 
Example 8 
A unidirectional scaffold was prepared generally in accor 
dance with Example 1 having a length of about 62 mm and a 
diameter of about 6 mm. The fibers were type 13-93 bioactive 
glass fibers having a length of about 62 mm and a diameter of 
about 50 to 400 microns. The fibers were oriented in longi 
tudinal co-alignment defining the length of the scaffold with 
an added reinforcing rod placed at the center of the fibers prior 
to self-bonding. FIG. 10 is a schematic pictorial demonstrat 
ing this concept of placing a reinforcement of Ti or other 
metal or alloy or Supporting material in the center of a self 
bonded unidirectional bioactive glass fiber scaffold. FIG. 11 
is a photograph of the reinforced unidirectional bioactive 
glass scaffold prepared with a Tirod placed in the center of a 
bundle of fibers, and heated so that the fibers self-bonded and 
also attached to the rod, in accordance with this example. 
FIG. 12 is a schematic pictorial demonstrating an alterna 
tive concept of filling a hollow reinforcing tube of Tior other 
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metal or alloy or polymer including biodegradable polymers 
such as PCL or PLA or other supporting material with unidi 
rectional glass fiber followed by self-bonding to form the 
scaffold. The tube is, for example, made of titanium or any 
12 
into and lengthwise within the scaffold; and wherein the 
fibers are self-bonded together in that adjacent longitu 
dinally aligned fibers are fused together. 
2. The scaffold of claim 1 wherein the fibers are bioactive 
other reinforcing material with similar thermal expansion 5 glass fibers. 
properties of the glass so the scaffold bonds to the tube as the 
fibers self-bond. This may be beneficial in promoting bone 
ingrowth in prosthesis Such as hip implants by inserting glass 
fibers into and around the implant as a means for improved 
bone attachment and ingrowth. FIG. 12 demonstrates an 
aspect of the invention, as with FIGS. 1A, 1B, and 1C, in that 
the fibers extending lengthwise of the scaffold central axis 
define channels lengthwise through a core within the scaffold. 
This is distinct from the alternative in FIG. 11, in which the 
core is occupied by a reinforcing rod rather than by channel 
defining fibers. 
FIG. 13 is a schematic pictorial demonstrating a further 
alternative concept of a unidirectional bioactive glass scaffold 
filled with a polymer phase. Suitable polymers include those 
such as bone cement (PMMA) or biodegradable polymers 
such as PCL or PLA, as the polymer phase is used for sus 
tained reinforcement (PMMA) or an initial reinforcement 
followed by a slow degradation of biodegradable polymer 
allowing new tissue to fill in with time. These methods asso 
ciated with FIGS. 10-13 can be practiced individually or in 
any combination for constructing or implementing a rein 
forced unidirectional bioactive glass scaffold. These embodi 
ments are distinct from the embodiments featured in FIGS. 8 
and 9, where the scaffold body consists essentially of the 
fibers and porosity as described herein. 
In view of the above, it will be seen that the several objects 
of the invention are achieved and other advantageous results 
attained. 
When introducing elements of the present invention or the 
preferred embodiments(s) thereof, the articles “a”, “an', 
“the' and “said are intended to mean that there are one or 
more of the elements. The terms “comprising”, “including 
and “having are intended to be inclusive and mean that there 
may be additional elements other than the listed elements. 
AS Various changes could be made in the above composi 
tions and methods without departing from the scope of the 
invention, it is intended that all matter contained in the above 
description and shown in the accompanying drawings shall be 
interpreted as illustrative and not in a limiting sense. 
The invention claimed is: 
1. A tissue scaffold for repair and regeneration of bone hard 
tissue or muscle, skin, or organ Soft tissue, the scaffold com 
prising: 
a rigid scaffold body having a scaffold central axis, a scaf 
fold transverse dimension, and a scaffold lengthwise 
dimension which is greater than the scaffold transverse 
dimension, the scaffold body having a compressive 
strength between about 20 and about 250 MPa and com 
prising: 
biocompatible inorganic glass fibers each having a fiber 
transverse dimension and a fiber lengthwise dimension 
which is at least about 10 times the fiber transverse 
dimension; and 
an interconnected porosity constituting between about 10 
vol.% and about 35 vol.% of the scaffold body; 
wherein each of the fibers has a diameter between about 20 
and about 5000 microns; 
wherein at least about 75 vol% of the fibers are longitudi 
nally co-aligned and liegenerally lengthwise of the scaf 
fold central axis, are generally free of helical orientation 
about the scaffold central axis, and are arranged to define 












3. The scaffold of claim 1 wherein each fiberamong the at 
least about 75 vol% of fibers has an alignment along at least 
about 75% of its length which does not deviate more than 
about 25 degrees from parallel to the central axis of the 
scaffold. 
4. The scaffold of claim 1 wherein each fiberamong the at 
least about 75 vol% of fibers has an alignment along at least 
about 75% of its length which does not deviate more than 
about 10 degrees from parallel to the central axis of the 
scaffold. 
5. The scaffold of claim 1 wherein each fiberamong the at 
least about 75 vol% of fibers is generally straight. 
6. The scaffold of claim 1 wherein each fiberamong the 75 
vol% of fibers has an alignment along at least 75% of its 
length which is within 10 degrees of a mean straight central 
axis for said fiber. 
7. The scaffold of claim 1 wherein each fiberamong the 75 
vol% of fibers has an alignment along at least 95% of its 
length within 10 degrees of a mean Straight central axis for 
said fiber. 
8. The scaffold of claim 1 wherein the scaffold body con 
sists essentially of the longitudinally co-aligned, bonded 
together glass fibers and the porosity. 
9. The scaffold of claim 1 wherein the fibers and the poros 
ity cumulatively constitute at least about 75 Vol.% of the 
scaffold body. 
10. The scaffold of claim 1 wherein the scaffold body 
further comprises a reinforcement of the scaffold body. 
11. The scaffold of claim 1 wherein the scaffold body 
further comprises a reinforcement to which some fibers 
among said fibers of the scaffold body are bonded. 
12. The scaffold of claim 1 wherein each fiberamong the at 
least about 75 vol% of fibers has an alignment along at least 
about 75% of its length which does not deviate more than 
about 25 degrees from parallel to the central axis of the 
scaffold; and 
wherein each fiber among the 75 vol% of fibers has an 
alignment along at least 75% of its length which is 
within 10 degrees of a mean straight central axis for said 
fiber. 
13. The scaffold of claim 1 wherein each fiberamong the at 
least about 75 vol% of fibers has an alignment along at least 
about 75% of its length which does not deviate more than 
about 10 degrees from parallel to the central axis of the 
scaffold; and 
wherein each fiber among the 75 vol% of fibers has an 
alignment along at least 85% of its length which is 
within 10 degrees of a mean straight central axis for said 
fiber. 
14. A tissue scaffold for repair and regeneration of bone 
hard tissue or muscle, skin, or organ soft tissue, the scaffold 
comprising: 
a rigid scaffold body having a central axis, a scaffold trans 
verse dimension, and a scaffold lengthwise dimension 
which is greater than the scaffold transverse dimension, 
the scaffold body having a compressive strength 
between about 20 and about 250 MPa and comprising: 
biocompatible inorganic glass fibers each having a fiber 
transverse dimension and a fiber lengthwise dimension 
which is at least about 10 times the fiber transverse 
dimension; and 
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an interconnected porosity constituting between about 10 
vol.% and about 35 vol.% of the scaffold body; 
wherein each of the fibers has a diameter between about 20 
and about 5000 microns; 
wherein at least about 75 vol% of the fibers extend gener 
ally parallel to the scaffold central axis, and are arranged 
to define open channels within the scaffold which allow 
fluid flow into and lengthwise within the scaffold; and 
wherein the fibers are self-bonded together in that adja 
cent longitudinally aligned fibers are fused together. 
15. The scaffold of claim 14 wherein the fibers are bioac 
tive glass fibers. 
16. The scaffold of claim 14 wherein each fiber among the 
at least about 75 vol% of fibers has an alignmentalong at least 
about 75% of its length which does not deviate more than 
about 25 degrees from parallel to the central axis of the 
scaffold. 
17. The scaffold of claim 14 wherein each fiber among the 
at least about 75 vol% of fibers has an alignmentalong at least 
about 75% of its length which does not deviate more than 
about 10 degrees from parallel to the central axis of the 
scaffold. 
18. The scaffold of claim 14 wherein each fiber among the 
at least about 75 vol% of fibers is generally straight. 
19. The scaffold of claim 14 wherein each fiber among the 
75 vol% of fibers has an alignment along at least 75% of its 
length which is within 10 degrees of a mean straight central 
axis for said fiber. 
20. The scaffold of claim 14 wherein each fiberamong the 
75 vol% of fibers has an alignment along at least 95% of its 
length within 10 degrees of a mean Straight central axis for 
said fiber. 
21. The scaffold of claim 14 wherein the scaffold body 
further comprises a reinforcement of the scaffold body. 
22. The scaffold of claim 14 wherein the scaffold body 
further comprises a reinforcement to which some fibers 
among said fibers of the scaffold body are bonded. 
23. The scaffold of claim 14 wherein each fiberamong the 
at least about 75 vol% of fibers has an alignmentalong at least 
about 75% of its length which does not deviate more than 
about 25 degrees from parallel to the central axis of the 
scaffold; and 
wherein each fiber among the 75 vol% of fibers has an 
alignment along at least 75% of its length which is 
within 10 degrees of a mean straight central axis for said 
fiber. 
24. The scaffold of claim 14 wherein each fiberamong the 
at least about 75 vol% of fibers has an alignmentalong at least 
about 75% of its length which does not deviate more than 
about 10 degrees from parallel to the central axis of the 
scaffold; and 
wherein each fiber among the 75 vol% of fibers has an 
alignment along at least 85% of its length which is 
within 10 degrees of a mean straight central axis for said 
fiber. 
25. The scaffold of claim 14 wherein the scaffold body 
consists essentially of the glass fibers and the porosity. 
26. The scaffold of claim 14 wherein the fibers and the 
porosity cumulatively constitute at least about 75 Vol.% of 













27. A tissue scaffold for repair and regeneration of bone 
hard tissue or muscle, skin, or organ soft tissue, the scaffold 
comprising: 
a scaffold body having a central axis, a scaffold transverse 
dimension, and a scaffold lengthwise dimension which 
is greater than the scaffold transverse dimension, the 
Scaffold body comprising: 
biocompatible inorganic glass fibers each having a fiber 
transverse dimension and a fiber lengthwise dimension 
which is at least about 10 times the fiber transverse 
dimension; and 
an interconnected porosity constituting between about 10 
vol.% and about 35 vol.% of the scaffold body; 
wherein each of the fibers has a diameter between about 20 
and about 5000 microns; 
wherein at least about 75 vol% of the fibers are longitudi 
nally co-aligned and lie generally lengthwise of the scaf 
fold central axis, and are arranged to define open chan 
nels lengthwise through a core within the scaffold, 
which channels allow fluid flow into and lengthwise 
within the scaffold; and wherein the fibers are self 
bonded together in that adjacent longitudinally aligned 
fibers are fused together. 
28. The scaffold of claim 27 wherein the fibers are bioac 
tive glass fibers. 
29. The scaffold of claim 27 wherein at least about 75 vol 
% of the fibers occupies the entire length of the scaffold. 
30. A tissue scaffold comprising: 
a rigid scaffold body having a scaffold central axis, a scaf 
fold transverse dimension, and a scaffold lengthwise 
dimension which is greater than the scaffold transverse 
dimension, the scaffold body having a compressive 
strength between about 20 and about 250 MPa and com 
prising: 
biocompatible inorganic glass fibers each having a fiber 
transverse dimension and a fiber lengthwise dimension 
which is at least about 10 times the fiber transverse 
dimension; and 
an interconnected porosity constituting between about 10 
vol.% and about 35 vol.% of the scaffold body; 
wherein each of the fibers has a diameter between about 20 
and about 5000 microns; 
wherein at least about 75 vol% of the fibers are longitudi 
nally co-aligned and lie generally lengthwise of the scaf 
fold central axis, are generally free of helical orientation 
about the scaffold central axis, and are arranged to define 
open channels within the scaffold which allow fluid flow 
into and lengthwise within the scaffold; wherein the 
fibers are self-bonded together in that adjacent longitu 
dinally aligned fibers are fused together, and 
wherein the scaffold further comprises a biocompatible 
support rod incorporated into the scaffold to provide 
additional mechanical strength. 
31. A tissue scaffold comprising: 
a rigid scaffold body having a scaffold central axis, a scaf 
fold transverse dimension, and a scaffold lengthwise 
dimension which is greater than the scaffold transverse 
dimension, the scaffold body having a compressive 
strength between about 20 and about 250 MPa and com 
prising: 
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biocompatible inorganic glass fibers each having a fiber fold central axis, are generally free of helical orientation 
transverse dimension and a fiber lengthwise dimension about the scaffold central axis, and are arranged to define 
which is at least about 10 times the fiber transverse open channels within the scaffold which allow fluid flow 
dimension; and into and lengthwise within the scaffold; and 
an interconnected porosity constituting between about 10 wherein the biocompatible glass fibers comprise both bio 
active fibers and bioinert fibers. 
vol.% and about 35 vol.% of the scaffold body; 32. The ti ffold of claim 31 wherein the bi 
wherein each of the fibers has a diameter between about 20 . The t1SSue scalIola oi claim 31 w erein the blocompat ible Support rod is titanium. 
and about 5000 microns; 33. The tissue scaffold of claim 31 wherein the fibers are 
wherein the fibers are bonded together; '' attached to the rod. 
wherein at least about 75 vol% of the fibers are longitudi 
nally co-aligned and liegenerally lengthwise of the scaf- k . . . . 
